My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Aurinia Pharmaceuticals Inc - Common Shares (NQ:AUPH)

14.23 -0.08 (-0.56%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Aurinia Pharmaceuticals Inc - Common Shares

< Previous 1 2 3 4 5 6 7 Next >

What 4 Analyst Ratings Have To Say About Aurinia Pharmaceuticals ↗

March 08, 2022

Over the past 3 months, 4 analysts have published their opinion on Aurinia Pharmaceuticals (NASDAQ:AUPH) stock. These analysts are typically employed by large Wall Street banks...

Via Benzinga

10 Biggest Price Target Changes For Tuesday ↗

March 08, 2022

Raymond James cut the price target on Ciena Corporation (NYSE: CIEN) from $80 to $75. Ciena shares fell 10.9% to close at $58.76 on Monday. Telsey Advisory Group cut Capri...

Via Benzinga

67 Biggest Movers From Yesterday ↗

March 01, 2022

Gainers Mullen Automotive, Inc. (NASDAQ: MULN) climbed 145.6% to close at $1.69 on Monday after the company reported progress on solid-state polymer battery pack...

Via Benzinga

Why Aurinia Pharmaceuticals Tumbled Despite Its 'Aggressive' 2022 Outlook ↗

February 28, 2022

The company expects 150%-200% growth in its key product. But that wasn't enough.

Via Investor's Business Daily

42 Stocks Moving In Monday's Mid-Day Session ↗

February 28, 2022

Gainers Mullen Automotive, Inc. (NASDAQ: MULN) jumped 74.4% to $1.20 after the company reported progress on solid-state polymer battery pack development. Renewable Energy Group...

Via Benzinga

Stocks Mixed as Investors Weigh Sanctions ↗

February 28, 2022

U.S. markets have cut a great deal of this morning's losses, though the Dow Jones Industrial Average (DJI) is still down

Via Talk Markets

Why Aurinia Pharmaceuticals Shares Are Falling Today ↗

February 28, 2022

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) is trading significantly lower Monday after the company reported declining fourth-quarter financial results on a year-over-year basis....

Via Benzinga

Earnings Scheduled For February 28, 2022 ↗

February 28, 2022

Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth quarter. • Praxis Precision Medicine (...

Via Benzinga

Expert Ratings For Aurinia Pharmaceuticals ↗

December 10, 2021

Within the last quarter, Aurinia Pharmaceuticals (NASDAQ:AUPH) has observed...

Via Benzinga

Mid-Morning Market Update: Markets Open Lower Amid Ongoing Russia-Ukraine Conflict ↗

February 28, 2022

U.S. stocks opened on a downbeat note this morning, amid the ongoing Russia-Ukraine conflict, which has led to increased US sanctions on Russia. Following the market opening...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 10, 2021 ↗

December 10, 2021

Upgrades According to JP Morgan, the prior rating for Arconic Corp (NYSE:

Via Benzinga

Aurinia's Voclosporin Shows favorable Risk/Benefit Profile Over 3 Years In Lupus Nephritis ↗

December 09, 2021

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) has posted topline results from the AURORA 2 continuation study evaluating the long-term safety and tolerability of...

Via Benzinga

The Daily Biotech Pulse: Reata Plunges On Adcom Snub, AstraZeneca Antibody Cocktail Authorized For COVID-19 Prevention, NeuroSense IPO ↗

December 09, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus FDA Committee Votes Against Recommending Approval Of Kidney Disease Drug...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

December 09, 2021

Good morning, trader! It's time to kick off another busy day of trading with the biggest pre-market stock movers for Thursday!

Via InvestorPlace

61 Biggest Movers From Yesterday ↗

December 03, 2021

Gainers Jowell Global Ltd. (NASDAQ: JWEL) jumped 25.5% to close at $13.36. Jowell Global recently announced a collaboration with Unilever's Uni-Excubator. Information...

Via Benzinga

Aurinia Pharma Surges Again As Novartis Joins List Of Potential Suitors ↗

December 02, 2021

Aurinia Pharma popped after Novartis said it's focused on bolt-on deals.

Via Investor's Business Daily

EXPR Stock: 7 Reasons Why Express Investors Are Feeling Giddy Today ↗

December 02, 2021

Investors in Express (EXPR) stock are celebrating on Thursday thanks to the release of the company's Q3 2021 earnings report.

Via InvestorPlace

BFRI Stock: The News That Has Biofrontera Shares Bounding Higher Today ↗

December 02, 2021

Biofrontera (BFRI) stock is getting a boost on Thursday thanks to an update from the United States Patent and Trademark Office.

Via InvestorPlace

Topics Intellectual Property

AUPH Stock: The Novartis Takeover Talk That Has Aurinia Pharma Shares Taking Off Today ↗

December 02, 2021

Aurinia Pharma (AUPH) stock is on the rise Thursday as investors hold out hope for a takeover of the company by Novartis (NVS).

Via InvestorPlace

40 Stocks Moving In Thursday's Mid-Day Session ↗

December 02, 2021

Gainers Biofrontera Inc. (NASDAQ: BFRI) surged 39% to $6.02. Biofrontera announced Notice of Allowance for U.S. patent titled 'Illumination for Photodynamic Therapy.'...

Via Benzinga

Topics Intellectual Property

Tuesday Markets Review ↗

November 30, 2021

The oil price did not fall as expected over the White House release of 50 mn bbls of oil.

Via Talk Markets

61 Biggest Movers From Yesterday ↗

November 23, 2021

Gainers Longeveron Inc. (NASDAQ: LGVN) shares surged 181.2% to settle at $28.20 on Monday on continued upward momentum after the company last week announced the FDA granted Rare...

Via Benzinga

Mid-Afternoon Market Update: Dow Rises 200 Points; Niu Technologies Shares Slide ↗

November 22, 2021

Toward the end of trading Monday, the Dow traded up 0.59% to 35,811.07 while the NASDAQ fell 0.43% to 15,989.15. The S&P also rose, gaining 0.43% to 4,718.05. The U.S. has the...

Via Benzinga

Topics Stocks

Is An Aurinia Pharmaceuticals Buyout Coming? Why This Has Investors Doubting It ↗

November 22, 2021

Aurinia tanked Monday as an SEC filing had investors questioning buyout rumors.

Via Investor's Business Daily

Topics Regulatory Compliance

Financial Stocks: WFC, MS, C, BAC, JPM and GS Gain on Powell Fed Chairman’s Second Term ↗

November 22, 2021

Financial stocks are doing well on Monday thanks to an update from the U.S. Government concerning the next Federal Reserve chairman.

Via InvestorPlace

Topics Economy

AUPH Stock: 13 Things to Know About Aurinia Pharma as Shares Crash Today ↗

November 22, 2021

Aurinia Pharma (AUPH) stock is taking a beating on Monday following a filing with the SEC after markets closed on Friday.

Via InvestorPlace

Topics Regulatory Compliance

Mid-Day Market Update: Gold Down 2%; iSpecimen Shares Spike Higher ↗

November 22, 2021

Midway through trading Monday, the Dow traded up 0.65% to 35,832.70 while the NASDAQ rose 0.67% to 16,164.51. The S&P also rose, gaining 0.87% to 4,738.91. The U.S. has the...

Via Benzinga

Topics Stocks

40 Stocks Moving In Monday's Mid-Day Session ↗

November 22, 2021

Gainers iSpecimen Inc. (NASDAQ: ISPC) shares climbed 126.5% to $11.12 after the company announced it has been contracted to support new advanced research on COVID-19 seeking...

Via Benzinga

Here's Why Aurinia Pharmaceuticals Is Falling Today ↗

November 22, 2021

The company's recently filed unlimited shelf registration statement is making shareholders queasy.

Via The Motley Fool

Mid-Morning Market Update: Markets Open Higher; Avaya Tops Q4 Views ↗

November 22, 2021

Following the market opening Monday, the Dow traded up 0.77% to 35,876.58 while the NASDAQ rose 0.91% to 16,203.01. The S&P also rose, gaining 0.91% to 4,740.94. The U.S. has...

Via Benzinga

Topics Stocks

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.